Diagnostic testing

Multiplex PCR

Syndromic testing with QIAstat-Dx

To support the efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN has developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge enables detection of the SARS-CoV-2 virus that causes COVID-19 in addition to 20+ other respiratory pathogens.*

Discover Qiastat-Dx

QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge, technician, woman, lab tech, lab, laboratory

*The number of targets/pathogens detected by the QIAstat-Dx Respiratory SARS-CoV-2 Panels is different in different countries.

High throughput, multiplex testing with NeuMoDx

The NeuMoDx 96 and NeuMoDx 288 systems offer rapid and fully automated PCR for the detection of SARS-CoV-2 along with influenza A/B and RSV. Within 80 minutes, your lab can get fast and accurate answers – supporting actionable clinical decisions.

Discover NeuMoDx

Automated targeted PCR

Rapid high-throughput targeted testing with NeuMoDx

The NeuMoDx 96 and NeuMoDx 288 systems offer a rapid and fully automated PCR test for the detection of SARS-CoV-2 that can deliver a result in about an hour. NeuMoDx systems provide an ideal solution for hospitals or central testing labs, delivering the speed and flexibility to support the large numbers of patient samples they receive.

Discover NeuMoDx

NeuMoDx, NMDx, N96, N288, NeuMoDx 96, NeuMoDx 288, automation, infectious disease, IDx, molecular diagnostics, MDx, instrument

Manual targeted PCR

Increase lab throughput with our innovative liquid sample prep

The artus SARS-CoV-2 Prep&Amp UM Kit is an innovative liquid-based kit for SARS-CoV-2 detection. With fewer and simpler workflow steps, you can accelerate your lab's turnaround time while decreasing plastic usage, cost and hands-on time. With artus Prep&Amp, you integrate the sample preparation and the detection in a streamlined liquid workflow - getting quick results in 90 minutes.

Discover artus Prep&Amp

T cell detection

A new tool in the fight against COVID-19

Cell mediated immunity is an enduring and reliable marker of the adaptive immune response after COVID-19 vaccination. T cell responses to SARS-CoV-2 decline more slowly than antibody responses and may provide a more sensitive way to monitor immune responses to SARS-CoV-2 vaccination than serological assays alone. QuantiFERON SARS-CoV-2 features trusted QuantiFERON technology to measure cell mediated immune response after SARS-CoV-2 vaccination.

Discover QuantiFERON SARS-CoV-2

RNA extraction

RNA extraction solutions

We have an extensive portfolio of RNA extraction kits for purification of high-quality RNA. You can be confident in your downstream results because our kits help deliver highly pure nucleic acid free of contaminants and inhibitors. Options are available specific formats and throughputs, as well as for manual and automated processing.

group of scientist, talk, discussion, laboratory, diversity, wearing masks

For QIAcube classic information please visit our resource hub.

Additional COVID-19 resources

Research solution for COVID-19
Learn how QIAGEN can support research to better understand the SARS-CoV-2 virus.
read more
Latest COVID-19 updates from QIAGEN
Stay up-to-date with our latest news and product developments here.
read more
Battling tuberculosis in the time of COVID-19
Dr. Story brings tuberculosis testing and treatment to susceptible homeless communities during COVID-19.
read more
Tailored oligonucleotides for SARS-CoV-2 detection
OEM by QIAGEN provides customized primers and probes. We have ramped up and prioritized production that specifically supports SARS-CoV-2 detection.
read more

QIAGEN solutions

QIAstat-Dx
The next generation of syndromic insights
Harness the full potential of multiplex syndromic testing and confidently provide clinical insights to patients with the highest level of versatility.
FIND OUT MORE
QIAGEN Digital Insights
Bioinformatics analysis of SARS-CoV-2 with QIAGEN Digital Insights
To support the efforts of labs sequencing the SARS-CoV-2 virus on the front lines of the COVID-19 pandemic, QIAGEN is offering free temporary licenses to researchers worldwide involved with COVID-19 research and response.
FREE TEMPORARY LICENSE
QIAcube Connect
Redefining automated sample processing
Fully automate QIAGEN gold-standard spin-column purification procedures with the new QIAcube Connect instrument.
VIEW DEMO
EZ1 DSP Virus Kit
Contains all required reagents for automated purification
The EZ1 DSP Virus Kit is ideal for automated, simultaneous purification of viral nucleic acids and bacterial DNA from 1–6 or 1–14 human biological specimens.
FIND OUT MORE
QIAamp Viral RNA Mini Kit
For isolation of viral RNA from cell-free body fluids
By binding viral RNA to the QIAamp silica membrane, the QIAamp Viral RNA Mini Kit simplifies purification of viral RNA from cell-free body fluids with fast spin-column or vacuum procedures. The procedure can be fully automated.
FIND OUT MORE
EZ1 Advanced XL
For automated nucleic acid purification
With EZ1 Advanced XL you can fully automate your nucleic acid purification from a wide range of sample types relevant for molecular diagnostics.
FIND OUT MORE